Invest-IQ | Private Equity News – Europe

Forbion Capital Partners, the Dutch life sciences venture capital firm, today announces that it has led the expansion financing of the Series A round of Curetis AG together with Roche Venture Fund, CD-Venture and management. Curetis has developed a diagnostics platform to identify the pathogen that causes a patient’s pneumonia and which antibiotic resistance patterns [...]

AM-Pharma B.V., a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase (AP) for  treatment of severe inflammatory diseases, today announced that it has raised €29.2m in Series D financing. The series D round was led by Ysios Capital Partners, co-led by Kurma Life Science Partners and supported by a consortium including [...]

Forbion Capital Partners, the Dutch life sciences venture capital firm, today announces that it has led the Series A investment of Amakem NV, the ophthalmology company developing new treatments for serious eye conditions, with a syndicate of leading life sciences investors. Related Links: Press Release: Forbion Capital Partners lead €18 Million Financing of Amakem Investor: [...]

Forbion Capital Partners announces that MEDRAD, Inc, a subsidiary of Bayer Healthcare, has acquired portfolio company Pathway Medical Technologies, Inc. for an undisclosed sum. With this acquisition, Forbion successfully sells another portfolio company from its Fund I (FCFI). Related Links: Press Release: Forbion announces acquisition of Pathway Medical Technologies by Bayer Healthcare Investors: Forbion Capital [...]